EcoR1 Capital manages investment funds that primarily invest in equity and equity-related securities of biotechnology companies. These funds include the EcoR1 Capital Funds and the EcoR1 Venture Opportunity Funds. EcoR1 selects all investments and strategies for these funds, and investors have no opportunity to select or evaluate any fund investments or strategies. EcoR1 does not offer wrap fee programs.
EcoR1 Capital manages investments for private funds. The annual management fee for the EcoR1 Capital Funds is 2.0% of each investor’s capital account balance, payable quarterly. EcoR1 also receives a performance-based allocation equal to 20% of net profits. Fees and compensation for the Venture Funds and SPVs are calculated differently.